Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer Post published:January 11, 2021 Post category:Press Release
NeonMind Announces Grants Pursuant to Stock Option Plan Post published:January 11, 2021 Post category:Press Release
Lobe Sciences Announces Changes to Board of Directors Post published:January 8, 2021 Post category:Press Release
Psychedelic Bulletin: MindMed Raises $92.1m; Mount Sinai Establishes Psychedelics Centre; More Legal Exemptions for Psilocybin in Canada Post published:January 8, 2021 Post category:Psychedelic Bulletin
Review of Bipolar Disorders Confirms Early Diagnosis and Treatment Can Improve Patient Quality of Life Post published:January 8, 2021 Post category:Press Release
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care Post published:January 8, 2021 Post category:Press Release
Mount Sinai Health System Launches Center for Psychedelic Research Post published:January 7, 2021 Post category:Press Release
BetterLife Announces Formation of Next Generation Psychedelic Research Advisory Board Post published:January 7, 2021 Post category:Press Release
Ehave, Inc. Partners with Cognitive Apps to Add Artificial Intelligence-Powered Mental Health Analytical Platform for Psychedelic Use in G20 Countries Post published:January 7, 2021 Post category:Press Release
Ontario Brain Institute Increases Investment in Diamond Therapeutics to Accelerate Innovation in Mental Health Post published:January 7, 2021 Post category:Press Release